Highlights
NASDAQ: PIRS       Pieris Pharma
Last Price Today's Change   Day's Range   Trading Volume
3.29   -0.17 (4.91%)  3.28 - 3.46  428,100

Overview

 
Avg Volume (4 weeks):565,151
4 Weeks Range:3.19 - 4.214
4 Weeks Price Volatility (%):
9.77%
52 Weeks Range:2.39 - 6.04
52 Weeks Price Volatility (%):
24.66%
Average Price Target:-

Headlines



No recent Headlines for this stock.


Business Background

Pieris Pharmaceuticals Inc is a clinical-stage biopharmaceutical company, which engages in the discovery and development of Anticalin class of biotherapeutics. Anticalin proteins are engineered versions of lipocalins, human proteins that naturally bind, store and transport a wide spectrum of molecules. The company with the help of technology creates differentiated drugs such as PRS-080, PRS-060, PRS-343 and PRS-332 that can help patients suffering from cancer, severe asthma, anemia, and other medical conditions with a high unmet medical need. Geographically, all the operation of the firm is functioned through the region of US.

  Be the first to like this.
 


 

3995  4101  641  182 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 CELG 108.24+0.11 
 EEM 44.42-0.02 
 SPY 317.32+0.19 
 AMD 41.15-1.44 
 VXX 15.53-0.67 
 DHR 148.52-2.78 
 CHK 0.789+0.006 
 FXI 42.60-0.18 
 GE 11.34-0.10 
 BAC 34.44-0.24 
Partners & Brokers